EC approves expanded indication for Merck’s Pneumococcal 15-valent Conjugate Vaccine
The approval facilitates availability of Vaxneuvance for this population in all 27 European Union (EU) member states plus Iceland,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
VAXNEUVANCE
CDC ACIP votes to provisionally recommend Merck’s Vaxneuvance in series with Pneumovax 23
Series would be routinely recommended both for adults 65 years and older and for adults aged 19 to 64 at an increased risk for…
Merck gets US FDA nod of adult pneumococcal 15-valent conjugate vaccine
VAXNEUVANCE demonstrated non-inferior immune responses for the serotypes shared with PCV13 (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C,…